DLA Piper Facilitates Strategic Investment in ImmersiveTouch by HealthpointCapital

On July 2, 2025, DLA Piper, a prominent global law firm, announced its advisory role in the strategic investment of ImmersiveTouch, a leading digital surgery company, by HealthpointCapital, a private equity firm specializing in musculoskeletal healthcare. This investment will enable HealthpointCapital to acquire a majority stake in ImmersiveTouch, furthering its commitment to advancing healthcare technologies.

ImmersiveTouch is renowned for its innovative FDA 510(k)-cleared software that allows for real-time, hands-on surgical planning tailored to individual patient anatomies. The company’s flagship product, ImmersiveView™, utilizes proprietary virtual reality (VR) and augmented reality (AR) technologies to enhance surgical procedures through improved planning, navigation, and the development of customized surgical guides. According to Jay Banerjee, Co-Founder of ImmersiveTouch, "Healthpoint has deep medtech experience, shareholder alignment, and operational leadership. Together, we’ll scale our FDA-cleared technology, which has already supported more than 300 cases across more than 100 hospitals."

The transaction was led by DLA Piper partner Neil Vohra, supported by a robust team that included partners Matt Servies, Todd Mobley, and Jason Veit, as well as Of Counsel Isabel De Obaldia and associates Jessica Lowe, Jessica Stenglein, Dahlia Ali, and Austin Vincenzini. The firm’s Private Equity practice is recognized as the second most active globally, according to PitchBook, highlighting its extensive capability to provide strategic counsel to private equity funds and their portfolio companies.

The implications of this investment extend beyond just capital infusion. As highlighted by Dr. Sarah Johnson, Professor of Health Sciences at Stanford University, "The integration of advanced digital surgical tools is revolutionizing patient outcomes and streamlining surgical processes. Investments like these signify a shift toward tech-driven healthcare solutions that can enhance precision and efficiency in surgical practices."

Moreover, the collaboration with HealthpointCapital is expected to accelerate the development and deployment of ImmersiveTouch's technologies, positioning the firm at the forefront of the evolving landscape of musculoskeletal healthcare. Industry leaders emphasize the importance of such technological advancements in addressing the growing demand for minimally invasive surgical procedures and personalized medicine.

In summary, the strategic investment by HealthpointCapital into ImmersiveTouch exemplifies a significant step in the integration of digital technologies in healthcare, promising to enhance surgical practices and patient care. As the healthcare sector continues to innovate, partnerships like this will likely play a pivotal role in shaping the future of medical technology.

For further insights into the implications of this investment, the role of DLA Piper in private equity transactions, and the future of digital surgery technologies, experts recommend monitoring ongoing developments in both the legal and healthcare sectors.